UNSPSC 51312803: Fenethazine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H18N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8J97CUZ4HX, chemically known as 10h-phenothiazine-10-ethanamine, n,n-dimethyl-, monohydrochloride but generally known as fenethazine, which bears US NIH Compound Identifier 68223. European Medicines Agency schedules Fenethazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07558MIG.

UNSPSC 51312803 Fenethazine, a Commodity code, does not align with the state and local procurement activity posted under it. The code nominally refers to a specific pharmaceutical compound, yet the recent opportunities solicited under this code are for naloxone, safe drug deactivation systems, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceuticals and over-the-counter products—none of which involve fenethazine. State and local governments issuing under this code include county health agencies (Seminole County, Florida), state health and human services departments (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving Minnesota and Oregon). The scope of recent work spans pharmaceutical procurement for community health support, pharmacy benefit program modernization, and bulk generic and OTC product supply chains through authorized wholesalers.

Recent activity centers on Florida, Texas, and the upper Midwest. Seminole County posted an IFB on June 30, 2026 (due July 26, 2023) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries. The Texas HHS Commission issued an RFI on April 3, 2026 regarding direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. Most substantially, MMCAP posted an RFP on January 20, 2026 (due March 26, 2026) to establish multi-award contracts for generic pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, requiring vendors to work through AmerisourceBergen (Cencora), Cardinal Health, and Morris & Dickson as authorized wholesalers. The mismatch between the code name and actual solicitations suggests either a classification error in the source data or that fenethazine is incidental to the broader pharmaceutical procurement activity tagged here.